Vital Signs - Expediting time to market: How laboratory developed tests have expanded the IVD markets

Vital Signs - Expediting time to market: How laboratory developed tests have expanded the IVD markets

 

RELEASE DATE
12-Apr-2010
REGION
North America
Research Code: 9561-00-A4-00-00
SKU: HC00593-NA-MR_04066
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00593-NA-MR_04066

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on April 12, 2010, provides a strategic overview of how laboratory developed tests
have expanded the IVD markets. Additionally, a company spotlight is provided for Sakura Finetek USA, a global leader for advanced automation systems for anatomic pathology (AP) in both research and diagnostic environments. Reimbursement and regulatory news from the FDA is also provided for the week of March 22, 2010.

Table of Contents

This week's issue:

This issue of Vital Signs, released on April 12, 2010, provides a strategic overview of how laboratory developed tests have expanded the IVD markets. Additionally, a company spotlight is provided for Sakura Finetek USA, a global leader for advanced automation systems for anatomic pathology (AP) in both research and diagnostic environments. Reimbursement and regulatory news from the FDA is also provided for the week of March 22, 2010.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-A4-00-00
Is Prebook No